Cumberland Pharmaceuticals Inc. (CPIX) vs Polaryx Therapeutics, Inc. Common Stock (PLYX)
A side-by-side comparison of Cumberland Pharmaceuticals Inc. and Polaryx Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CPIX
Cumberland Pharmaceuticals Inc.
$7.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PLYX
Polaryx Therapeutics, Inc. Common Stock
$2.10HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CPIX vs PLYX
growth of $100 · dividends reinvested · last 1yCPIX +123.8% (+123.8%/yr)PLYX -94.1% (-94.1%/yr)CPIX compounded faster over this window
Log scale — wide-divergence pair
CPIX PLYX
CPIX vs PLYX: by the numbers
- •CPIX is the larger company ($107M vs $105M market cap).
- •Both run net losses; PLYX's is the smaller (0.00% vs -33.92% net margin).
- •CPIX pays a dividend (21.16% yield), while PLYX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CPIX | PLYX |
|---|---|---|
| P/S ratio | 3.42 | N/A |
| P/B ratio | 6.13 | 9.57 |
Profitability
| Metric | CPIX | PLYX |
|---|---|---|
| Gross margin | 83.37% | 0.00% |
| Operating margin | -6.27% | 0.00% |
| Net margin | -33.92% | 0.00% |
| ROE | -60.82% | -62.61% |
| ROIC | -34.77% | -47.75% |
Dividends
| Metric | CPIX | PLYX |
|---|---|---|
| Dividend yield | 21.16% | N/A |
Growth (annualized)
| Metric | CPIX | PLYX |
|---|---|---|
| Revenue CAGR (5Y) | 3.53% | N/A |
| Total return CAGR (5Y) | 25.62% | N/A |
Frequently asked
- Does CPIX or PLYX pay a bigger dividend?
- CPIX pays a dividend (21.16% yield), while PLYX has no payments in the available dividend history.
Go deeper
Dig into the metrics
Cumberland Pharmaceuticals dividend yieldCumberland Pharmaceuticals ROEPolaryx Therapeutics, Inc. Common Stock ROECumberland Pharmaceuticals operating marginPolaryx Therapeutics, Inc. Common Stock operating marginCumberland Pharmaceuticals revenue growthPolaryx Therapeutics, Inc. Common Stock revenue growthCumberland Pharmaceuticals free cash flowPolaryx Therapeutics, Inc. Common Stock free cash flow
Cumberland Pharmaceuticals & Polaryx Therapeutics, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.